ENTRADA THERAPEUTICS INC (TRDA:NASDAQ)
$13.07 -0.49 (-3.6136%)
Analysed ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) News Sources
Sector Update: Health Care Stocks Softer Late Afternoon
06-04-2026
yahoo.com
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
18-03-2026
fool.com
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
18-03-2026
fool.com
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-03-2026
yahoo.com
Entrada Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
26-02-2026
yahoo.com
Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates
26-02-2026
yahoo.com
Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates
24-02-2026
yahoo.com
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
19-02-2026
yahoo.com
EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?
18-02-2026
yahoo.com
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study
17-02-2026
yahoo.com
What is the current price of ENTRADA THERAPEUTICS INC (TRDA:NASDAQ)?
The current price of ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) is $13.07.
ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) since the previous trading day is $-0.49.
ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) since the previous trading day is -3.6136%.
What is the most recent average sentiment score for ENTRADA THERAPEUTICS INC (TRDA:NASDAQ)?
The most recent average sentiment score for ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for ENTRADA THERAPEUTICS INC (TRDA:NASDAQ)?
The most recent sentiment for ENTRADA THERAPEUTICS INC (TRDA:NASDAQ) is .
SEC-8K** Filing Available For ENTRADA THERAPEUTICS INC (TRDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.